Sirt1/2-IN-2 is a dual inhibitor of SIRT1 and SIRT2 (IC50 = 1.8 μM for SIRT1 and 2.4 μM for SIRT2); it completely blocks p53 deacetylation, increases acetylation of p53 and α-tubulin, induces apoptosis, and exhibits antiproliferative activity against human leukemia cell lines.